CSL Vifor St. Gallen Secondary Packaging Employee

CSL Vifor Products

This is a complete list of all products marketed by CSL Vifor worldwide. Not all products are available in every country.

Visit the Global Selector to link to a specific country.

Iron deficiency and Iron deficiency anaemia

With our iron deficiency and iron deficiency anaemia expertise in heart failure, kidney disease, gastroenterology and inflammatory bowel disease, patient blood management and woman’s health, we help patients affected by these conditions to live better, healthier lives.

Ferinject® I Ferric Carboxymaltose Intravenous Iron

Venofer® I Iron Sucrose Low-dose Intravenous Iron

Maltofer® I Oral Iron Polymaltose Complex

Nephrology

We partner with specialists to improve the lives of patients with high unmet medical needs across all stages of kidney disease. Through our broad portfolio we aim to preserve renal function, manage complications and improve quality of life by addressing the full spectrum of kidney disease.

Veltassa® I Patiromer

Rayaldee® I Prolonged-release Formulation of Calcifediol

Tavneos® I Avacopan, Oral Elective Inhibitor of C5aR1

Mircera® I Long-acting Erythropoiesis-stimulating Agent

Retacrit® I Epoetin Alfa-epbx

Velphoro® I Sucroferric Oxyhydroxide

Korsuva® I Difelikefalin, Peripherally Restricted Kappa Opioid Receptor Agonist

Also marketed as Kapruvia^®. Approved and launched in the US. Also approved in the EU and launched in Germany, Austria, Sweden and France; approved in the UK, in Canada (partnered with Otsuka), Switzerland, Singapore and Australia, UAE, Kuwait and Israel (partnered with CTS).